Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Lorena Moran"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Minerva. 1:23-34
Las naciones y pueblos indígenas presentan preocupantes índices respecto a la salud, así como otras carencias como la pérdida de sus tierras, la alimentación, la educación y, en general, el ejercicio de sus derechos, consagrados por organizacio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::721420ec86c7ab9daea4fe9e1e14fca9
https://doi.org/10.47460/minerva.v1i3.14
https://doi.org/10.47460/minerva.v1i3.14
Autor:
Franco Locatelli, Marisa De Rosa, Andrea Pession, Anna Maria Testi, Owen P. Smith, Daniela Diverio, Gertjan J.L. Kaspers, David Grimwade, Alfonso Piciocchi, Brenda Gibson, Sarah Elitzur, Francesco Lo Coco, Henrik Hasle, Lorena Moran, Jutte van der Werff ten Bosch, Amilcar Cardoso de Azevedo, Guy Leverger, Robin Foà
Publikováno v:
Testi, A M, Pession, A, Diverio, D, Grimwade, D, Gibson, B, de Azevedo, A C, Moran, L, Leverger, G, Elitzur, S, Hasle, H, van der Werff Ten Bosch, J, Smith, O, De Rosa, M, Piciocchi, A, Lo Coco, F, Foà, R, Locatelli, F & Kaspers, G J L 2018, ' Risk-adapted treatment of acute promyelocytic leukemia : results from International Consortium for Childhood APL ', Blood, vol. 132, no. 4, pp. 405-412 . https://doi.org/10.1182/blood-2018-03-836528
Blood, 132(4), 405-412. American Society of Hematology
Testi, A M, Pession, A, Diverio, D, Grimwade, D, Gibson, B, Cardoso de Azevedo, A, Moran, L, Leverger, G, Elitzur, S, Hasle, H, van der Werff ten Bosch, J, Smith, O, de Rosa, M, Piciocchi, A, Lo Coco, F, Foà, R, Locatelli, F & Kaspers, G J L 2018, ' Risk-adapted treatment of acute promyelocytic leukemia: Results from the international consortium for childhood APL ', Blood, vol. 132, no. 4, pp. 405-412 . https://doi.org/10.1182/blood-2018-03-836528
Blood, 132(4), 405-412. American Society of Hematology
Testi, A M, Pession, A, Diverio, D, Grimwade, D, Gibson, B, Cardoso de Azevedo, A, Moran, L, Leverger, G, Elitzur, S, Hasle, H, van der Werff ten Bosch, J, Smith, O, de Rosa, M, Piciocchi, A, Lo Coco, F, Foà, R, Locatelli, F & Kaspers, G J L 2018, ' Risk-adapted treatment of acute promyelocytic leukemia: Results from the international consortium for childhood APL ', Blood, vol. 132, no. 4, pp. 405-412 . https://doi.org/10.1182/blood-2018-03-836528
Pediatric acute promyelocytic leukemia (APL), a rare childhood neoplasm, can be cured with all-trans retinoic acid (ATRA) and anthracycline. However, most published trials to date have employed high cumulative doses of anthracyclines. Here, we report
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea877667fffd70a7d4f5cc3ca3aeb4bd
https://pure.au.dk/portal/da/publications/riskadapted-treatment-of-acute-promyelocytic-leukemia(49c81af6-5904-4aa3-9213-40e80e556edc).html
https://pure.au.dk/portal/da/publications/riskadapted-treatment-of-acute-promyelocytic-leukemia(49c81af6-5904-4aa3-9213-40e80e556edc).html
Autor:
Guillermo Drelichman, Maria Fernanda Rivas Pereira, Leonardo Feldman, Maria Cores, Silvina Prada, Luis Aversa, Marcela Gutiérrez, Marcela Eugenia Soria, María Isabel Gaillard, Lorena Moran, Gimena Gil
Publikováno v:
Blood. 118:4238-4238
Abstract 4238 Introduction: Minimal residual disease (MRD) allows detection of blasts in patients in morphologically complete remission. Detection of MRD in patients with ALL is an independent risk factor associated with lower event-free survival (EF
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::128fe101c6b046a6b99876a3782df19f
https://doi.org/10.1182/blood.v118.21.4238.4238
https://doi.org/10.1182/blood.v118.21.4238.4238
Autor:
Graciela Schwalb, Alejandra Maro, Sandra Pennesi, Luis Aversa, Ana Awdejczuk, Daniel Freigeiro, Guillermo Drelichman, Nora Basack, Lorena Moran
Publikováno v:
Blood. 106:3751-3751
Inherited bone marrow failure syndromes (IBMFS) present chronic bone marrow failures, a familial incidence and high risk of malignancy. Objective: we describe our experience with patients with IBMFS. Since 02/73 to 02/05, 60 patients (pts) with IBMSF
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9165f301a1e69c7cd1716832e0a3f874
https://doi.org/10.1182/blood.v106.11.3751.3751
https://doi.org/10.1182/blood.v106.11.3751.3751
Publikováno v:
Psychology & Psychiatry Journal; 10/11/2024, p383-383, 1p
Publikováno v:
Hematology Week; 5/30/2023, p927-927, 1p